Cargando…

Development and evaluation of a virtual reality driving test for patients with cirrhosis

BACKGROUND: Patients with cirrhosis and especially those with HE may have impaired driving skills and may be prone to car accidents. This proof-of-concept study aimed to develop and evaluate the applicability of a virtual reality (VR)–based driving test in patients with cirrhosis. Additionally, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gairing, Simon J., Schleicher, Eva M., Kaps, Leonard, Schulte-Beerbuehl, Sophia, Steiner, Kristina, Labenz, Joachim, Schattenberg, Jörn M., Galle, Peter R., Wörns, Marcus-Alexander, Labenz, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617881/
https://www.ncbi.nlm.nih.gov/pubmed/37902506
http://dx.doi.org/10.1097/HC9.0000000000000303
_version_ 1785129671067697152
author Gairing, Simon J.
Schleicher, Eva M.
Kaps, Leonard
Schulte-Beerbuehl, Sophia
Steiner, Kristina
Labenz, Joachim
Schattenberg, Jörn M.
Galle, Peter R.
Wörns, Marcus-Alexander
Labenz, Christian
author_facet Gairing, Simon J.
Schleicher, Eva M.
Kaps, Leonard
Schulte-Beerbuehl, Sophia
Steiner, Kristina
Labenz, Joachim
Schattenberg, Jörn M.
Galle, Peter R.
Wörns, Marcus-Alexander
Labenz, Christian
author_sort Gairing, Simon J.
collection PubMed
description BACKGROUND: Patients with cirrhosis and especially those with HE may have impaired driving skills and may be prone to car accidents. This proof-of-concept study aimed to develop and evaluate the applicability of a virtual reality (VR)–based driving test in patients with cirrhosis. Additionally, the association between the results in the VR test and car accidents was investigated. METHODS: A short driving test using a VR head–mounted display (HTC Vive Pro Eye) was developed to simulate five hazardous situations. The patient has to pull the brake when the hazardous situations occur. The time from triggering the event to pressing the brake is recorded as reaction time. Total reaction time (TRT) is defined as the combined reaction time to all 5 events. Car accidents were assessed retrospectively (previous 12 months) and patients were followed prospectively for 6 months. Minimal HE (MHE) was diagnosed using Psychometric Hepatic Encephalopathy Score. RESULTS: In total, 112 outpatients with cirrhosis and 52 controls without cirrhosis were recruited. MHE was detected in 14% (n = 15). Patients with cirrhosis and MHE (5.67 s) had higher TRTs compared to patients without MHE (5.02 s) and controls without cirrhosis above the age of 50 (4.98 s) (MHE vs. no MHE or controls p<0.01, no MHE vs. controls: not significant). Seven patients reported car accidents during the twelve months prior to study inclusion. TRTs were numerically higher in patients with reported car accidents (p = 0.099). When patients who stopped driving for HE-related/cirrhosis-related reasons (n = 14) were added to the group of patients with accidents, then a longer TRT was significantly associated with the modeled outcome in univariable (p<0.01) and multivariable analyses (OR 2.83, p<0.01). Two car accidents occurred during follow-up. Both patients had TRTs above the 90th percentile. CONCLUSIONS: The VR driving test is easy and rapid to perform in patients with cirrhosis and could be helpful as a point-of-care tool for predicting car accidents.
format Online
Article
Text
id pubmed-10617881
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106178812023-11-01 Development and evaluation of a virtual reality driving test for patients with cirrhosis Gairing, Simon J. Schleicher, Eva M. Kaps, Leonard Schulte-Beerbuehl, Sophia Steiner, Kristina Labenz, Joachim Schattenberg, Jörn M. Galle, Peter R. Wörns, Marcus-Alexander Labenz, Christian Hepatol Commun Original Article BACKGROUND: Patients with cirrhosis and especially those with HE may have impaired driving skills and may be prone to car accidents. This proof-of-concept study aimed to develop and evaluate the applicability of a virtual reality (VR)–based driving test in patients with cirrhosis. Additionally, the association between the results in the VR test and car accidents was investigated. METHODS: A short driving test using a VR head–mounted display (HTC Vive Pro Eye) was developed to simulate five hazardous situations. The patient has to pull the brake when the hazardous situations occur. The time from triggering the event to pressing the brake is recorded as reaction time. Total reaction time (TRT) is defined as the combined reaction time to all 5 events. Car accidents were assessed retrospectively (previous 12 months) and patients were followed prospectively for 6 months. Minimal HE (MHE) was diagnosed using Psychometric Hepatic Encephalopathy Score. RESULTS: In total, 112 outpatients with cirrhosis and 52 controls without cirrhosis were recruited. MHE was detected in 14% (n = 15). Patients with cirrhosis and MHE (5.67 s) had higher TRTs compared to patients without MHE (5.02 s) and controls without cirrhosis above the age of 50 (4.98 s) (MHE vs. no MHE or controls p<0.01, no MHE vs. controls: not significant). Seven patients reported car accidents during the twelve months prior to study inclusion. TRTs were numerically higher in patients with reported car accidents (p = 0.099). When patients who stopped driving for HE-related/cirrhosis-related reasons (n = 14) were added to the group of patients with accidents, then a longer TRT was significantly associated with the modeled outcome in univariable (p<0.01) and multivariable analyses (OR 2.83, p<0.01). Two car accidents occurred during follow-up. Both patients had TRTs above the 90th percentile. CONCLUSIONS: The VR driving test is easy and rapid to perform in patients with cirrhosis and could be helpful as a point-of-care tool for predicting car accidents. Lippincott Williams & Wilkins 2023-10-31 /pmc/articles/PMC10617881/ /pubmed/37902506 http://dx.doi.org/10.1097/HC9.0000000000000303 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Article
Gairing, Simon J.
Schleicher, Eva M.
Kaps, Leonard
Schulte-Beerbuehl, Sophia
Steiner, Kristina
Labenz, Joachim
Schattenberg, Jörn M.
Galle, Peter R.
Wörns, Marcus-Alexander
Labenz, Christian
Development and evaluation of a virtual reality driving test for patients with cirrhosis
title Development and evaluation of a virtual reality driving test for patients with cirrhosis
title_full Development and evaluation of a virtual reality driving test for patients with cirrhosis
title_fullStr Development and evaluation of a virtual reality driving test for patients with cirrhosis
title_full_unstemmed Development and evaluation of a virtual reality driving test for patients with cirrhosis
title_short Development and evaluation of a virtual reality driving test for patients with cirrhosis
title_sort development and evaluation of a virtual reality driving test for patients with cirrhosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617881/
https://www.ncbi.nlm.nih.gov/pubmed/37902506
http://dx.doi.org/10.1097/HC9.0000000000000303
work_keys_str_mv AT gairingsimonj developmentandevaluationofavirtualrealitydrivingtestforpatientswithcirrhosis
AT schleicherevam developmentandevaluationofavirtualrealitydrivingtestforpatientswithcirrhosis
AT kapsleonard developmentandevaluationofavirtualrealitydrivingtestforpatientswithcirrhosis
AT schultebeerbuehlsophia developmentandevaluationofavirtualrealitydrivingtestforpatientswithcirrhosis
AT steinerkristina developmentandevaluationofavirtualrealitydrivingtestforpatientswithcirrhosis
AT labenzjoachim developmentandevaluationofavirtualrealitydrivingtestforpatientswithcirrhosis
AT schattenbergjornm developmentandevaluationofavirtualrealitydrivingtestforpatientswithcirrhosis
AT gallepeterr developmentandevaluationofavirtualrealitydrivingtestforpatientswithcirrhosis
AT wornsmarcusalexander developmentandevaluationofavirtualrealitydrivingtestforpatientswithcirrhosis
AT labenzchristian developmentandevaluationofavirtualrealitydrivingtestforpatientswithcirrhosis